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Abstract: The dural venous sinus thrombosis is a benign disease, representing about 1% 
of cerebral vascular events. In some cases the development of the disease increased 
intracranial pressure or symptomatic epilepsy. The development towards a dural venous 
sinus thrombosis is rare, but is a condition to be considered before the development of 
ischemic vascular events and a history of recent head trauma. Intracranial hematomas or 
skull fractures can lead to the establishment of obstructive pathology of the dural venous 
sinuses. The knowledge of this entity is necessary for the critical care staff and 
neurosurgery staff. 
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Introduction 
The dural sinus thrombosis (TSD) is a rare 
(1) event, which occurs most often in young 
adults and children, with an estimated adult 3-
4 incidence for 1,000,000 inhabitants, and 7 
per 1,000. 000 for children (2). Approximately 
75% of patients are women (3), with dominant 
3: 1 compared to men. The incidence when 
produced as a result of traumatic brain injury 
(TBI) is unknown; although some believe it is 
underdiagnosed because usually when the 
presence of TCE omitted this diagnosis is 
evaluated. Symptoms to establish a dural 
venous sinus thrombosis may be nonspecific, 
from mild headache to the development of 
severe neurological deficits including coma 
due to increased intracranial pressure 
associated with ischemic events and / or 
bleeding (4). 
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Risk factors 
 Once submitted TBI there are factors that 
act as promoters of the TSD, in fact in 85% of 
patients with cerebral sinus thrombosis are 
prothrombotic risk factors or direct causes (5). 
In the international study of thrombosis of the 
dural sinuses and cerebral veins (ISCVT), 
where 624 adults from 89 centers in 21 
countries were included, it was found that 
genetic or acquired thrombophilia, and the use 
of oral contraceptives were Common risk 
factors (5), which may explain the female 
predominance of this entity (3). Other 
conditions considered TSD promoters are 
neoplasms, CNS disorders (and dural 
arteriovenous fistulas), hematologic, 
nephrotic syndrome, systemic vasculitis, 
central nervous system infections (bacterial 
meningitis, cerebral malaria) (6, 7), disease 
intestinal (5) inflammatory drugs (cisplatin 
(8), methotrexate, steroids), neurological 
surgery, lumbar puncture, pregnancy and 
postpartum period (7). Despite the long list of 
risk factors for approximately 20% of cases are 
considered idiopathic (3-5, 9). 
Pathogenesis 
When a TBI occurs with head injury, skull 
fractures or intracranial hematomas can 
generate thrombosis either by direct 
compression of the breast or endothelial 
damage in this, generating the activation of the 
coagulation system resulting in occlusion 
breast. It is unusual for the TSD occurs in the 
absence of diastasis of cranial sutures (10), 
when it occurs in these cases, it means that the 
associated mechanism is endothelial damage 
within the venous sinus. The brain also 
contains an abundance of thromboplastin that 
is released after injury cause abnormal 
hypercoagulable state leading to destruction of 
platelets and erythrocytes followed by 
thrombus formation (10). Cerebrospinal fluid 
normally drains into the superior sagittal 
sinus, through the arachnoid villi. Thrombosis 
of these sinuses leads to increased venous 
pressure, which changes the mechanism of 
absorption of cerebrospinal fluid (CSF), and 
consequently increases the intracranial 
pressure (2), added to this can generate 
cytotoxic and interstitial edema (11 ) and 
venous infarction located. This produces 
dilated and enlarged veins, edema and 
ischemic neuronal damage, with petechial 
hemorrhages, which can bind and bruising (2). 
The most affected areas are in order: 
transverse sinus, sagittal sinus, sigmoid sinus 
and straight sinus (11, 12). Often the 
coexistence of several affected breast (2). 
Clinical manifestations 
Headache is the main symptom in these 
patients, the intensity is still not considered 
pathognomonic of TSD, described intensity 
from mild to severe (3, 5). Other nonspecific 
manifestations described are: nausea, 
vomiting and papilledema (5, 10). The 
frequency of the appearance of symptoms 
including headache (70%), followed by 
convulsions (39.3%), paresis (37.2%), 
papilledema (28.3%), altered mental status 
(22%), aphasia (19.1%) , stupor or coma 
(13.9%), diplopia (13.5%) and visual deficit 
(13.2%) (3). 
 
 
 
 
 
 
448 | Moscote-Salazar et al - Traumatic dural venous sinus thrombosis 
 
 
 
 
 
 
 
Clinical Evaluation 
Conducting a thorough neurological 
examination is vital to ascertain the presence 
or absence of signs and symptoms, just as 
should look for the presence of fractures (4), to 
better approach and early treatment improves 
the patient's condition (5). Patients with 
increased intracranial pressure isolated, 
usually only have severe headache and 
diplopia if intracranial pressure is very high, 
the sixth cranial nerve compression. In the 
fundus papilledema is observed, with 
temporary visual impairment, which may be 
permanent (2). 
Diagnosis 
The diagnosis of this entity is by imaging 
studies. The first study used is computed 
tomography (CT) without contrast (12), 
which reveals: edema, indicating areas 
hyperdensity hemorrhagic infarction (40% of 
cases), accompanied by string sign, which is a 
hyperdense area with cortical vein 
thrombosed transverse sinus area (13, 14); and 
the sign of the empty delta (10) which is a 
triangular area of enhancement with a 
relatively attenuated in the region of the 
superior sagittal sinus, considered 
pathognomonic of this sinus thrombosis 
occurs in about 28.6% of center these patients 
and has been found associated with poor 
prognosis. The appearance of this sign is 
probably due to the increased flow of the 
abundant collateral dural venous circulation, 
the breast surrounding the thrombosed 
producing central low attenuation (15). 
However, the absence of these findings does 
not exclude the diagnosis (5). In more than 
25% of cases this study reported no 
abnormalities (5). 
Magnetic resonance imaging (MRI) is 
considered one of the best methods for 
diagnosis of this entity, because it allows the 
visualization of the intracranial vasculature, 
and can better determine the location and time 
of the thrombus within the dural sinus (5). On 
MRI, the thrombus is easily recognizable in the 
subacute phase (10), primarily to exploration 
on T1, around the 15th thrombus signal it 
appears strongly hyperintense on T1 and T2 
weighted images, perhaps this is the period of 
greatest important because it is where most 
diagnoses (16) are made. In the acute phase, 
the thrombus is isodense with brain on T1-
weighted images and low signal on T2-
weighted images. This aspect can be mistaken 
for blood flow; but by using magnetic 
resonance venography (MRV) no flow (11, 12) 
demonstrated. T2 has been proven more 
sensitive than single T1 or T2 .However, MRI 
and MRV are likely to flow artifacts techniques 
and in doubtful cases, particularly if deep 
venous infarction or cortical venous 
thrombosis, an endoluminal technique is 
suspected high resolution as conventional 
venography or CT is recommended (11). 
Gold standard diagnosis is digital 
subtraction angiography, but because it is 
invasive and difficult to access, only used in 
cases where there is doubt about the diagnosis 
has not been determined by other methods 
(10-12) or when it is suspected a longstanding 
TSD with RM images unclear (16). 
It has been proposed the use of D-dimer to 
assess the risk of TSD, in patients in the 
emergency room, it has reported a sensitivity 
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of 97.1% and a negative predictive value of 
99.6% and specificity of 91.2% with a positive 
predictive value of 55.7% (5), despite this, this 
test is not considered routine, and can be 
performed in all patients, and can be altered in 
the presence of coexisting conditions (5). 
Treatment 
The three pillars of treatment are: 
management of intracranial pressure, 
convulsions and antithrombotic prevention 
treatment (1). The goal of this therapy is to 
stop the underlying thrombotic process and 
prevent venous thrombosis of other sites that 
may potentially aggravate the clinical picture. 
In antithrombotic therapy, anticoagulation 
with heparin has long been the traditional 
treatment, even sometimes is used regardless 
of the presence of hemorrhage (17, 18). It has 
further been reported using long-term 
warfarin (4, 11, 12), of monitored so as to 
avoid overdose (11). 
Care should be taken in patients who 
undergo surgery immediately in the presence 
of a TCE, because in them is generally 
contraindicated postoperative 
anticoagulation, which can lead to progress 
TSD therefore requires the suspect Initial of 
this entity in the presence of TCE and even 
more if there are risk factors (4). 
The use of thrombolytic agents which lyse 
the clot has quickly emerged as a therapeutic 
modality, supported interventional 
neuroradiology techniques to release the agent 
locally at the site of thrombosis. No 
randomized, double-blind, placebo-controlled 
cases, that support thrombolysis as the first-
line therapy in patients with thrombosis of the 
cerebral venous sinuses, compared with 
unfractionated heparin. Numerous case 
reports and nonrandomized single study has 
shown that it is comparatively safe and can 
rescue patients rapidly deteriorate despite 
treatment with unfractionated heparin. This 
practice should be restricted to centers with 
experience in this therapy (19). It is indicated 
in patients with progressive deterioration and 
do not respond to anticoagulant therapy for 
rapid recanalization of the obstructed sinus (9, 
12). When thrombolytic therapy is 
administered within 72 hours of diagnosis, it 
has been demonstrated that complete 
recanalization is obtained in 56.5% and 43.5% 
partial recanalization in (9). Among the most 
commonly used thrombolytic agents include: 
urokinase (73.7%) followed by recombinant 
plasminogen tissue activator (tPA) (21.5%), 
and thrombectomy or angioplasty (12.2%) (9). 
In a retrospective study of 25 patients with 
dural sinus thrombosis the role played by 
cerebral venous congestion and the 
management of these patients Patients were 
administered anticoagulation showed a steady 
course, those who were given thrombolytic 
therapy had analyzed more outcome of 
adverse effects, and who underwent 
thrombectomy presented initial clinical 
worsening; demonstrating the benefits of 
antithrombotic therapy as the main 
management and the role they may have to 
thrombectomy and thrombolytic therapy in 
the development of central venous congestion. 
Apparently the only anticoagulant therapy is 
not appropriate in these patients when they 
develop cerebral venous congestion, perhaps 
due to the loss of collateral flow (20). 
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Consideration of local or systemic 
thrombolysis in patients clinically deteriorate 
despite adequate anticoagulation 
recommended. There is no consensus to 
determine the optimal medication, dose, route 
and method of administration (5). 
It is considered a serious event of great 
associated mortality, that causes a progressive 
deterioration of the patient or improving the 
clinical condition, which can lead to serious 
neurological complications or death if not 
treated in a timely manner (4, 11). It has 
reported a lower specific mortality of 10%, but 
neurologic deficits are present at follow-up 
17% of the survivors, and the consequences 
may require long-term rehabilitation (11). For 
best results, follow with neuroimaging at least 
1 year after the event. Due to increased 
intracranial pressure, which occurs in some 
cases, there may be compression of the optic 
nerve and visual impairments therefore 
monitoring is recommended together with 
ophthalmology (11). 
Conclusions 
Head trauma constitutes a risk factor for 
developing thrombosis of dural (21) venous 
sinuses. A correct clinical history and imaging 
studies allow us to make an accurate diagnosis 
and timely managing this complication. 
Especially in young patients with recent head 
trauma who develop symptoms of intracranial 
hypertension and which they should discard 
neurosurgical pathology or intracranial 
hematomas adjacent to venous structures (22-
24). Prognosis depends on the treatment and 
the other structures involved with head 
trauma. 
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